Elsevier

Neurobiology of Aging

Volume 29, Issue 2, February 2008, Pages 267-279
Neurobiology of Aging

Levodopa increases memory encoding and dopamine release in the striatum in the elderly

https://doi.org/10.1016/j.neurobiolaging.2006.10.009Get rights and content

Abstract

Normal aging is associated with a decrease in dopaminergic function and a reduced ability to form new motor memories with training. This study examined the link between both phenomena. We hypothesized that levodopa would (a) ameliorate aging-dependent deficits in motor memory formation, and (b) increase dopamine availability at the dopamine type 2-like (D2) receptor during training in task-relevant brain structures. The effects of training plus levodopa (100 mg, plus 25 mg carbidopa) on motor memory formation and striatal dopamine availability were measured with [11C]raclopride (RAC) positron emission tomography (PET). We found that levodopa did not alter RAC-binding potential at rest but it enhanced training effects on motor memory formation as well as dopamine release in the dorsal caudate nucleus. Motor memory formation during training correlated with the increase of dopamine release in the caudate nucleus. These results demonstrate that levodopa may ameliorate dopamine deficiencies in the elderly by replenishing dopaminergic presynaptic stores, actively engaged in phasic dopamine release during motor training.

Introduction

Normal aging is associated with decreased ability to form new memories (Hedden and Gabrieli, 2004, Jay, 2003, Kandel and Pittenger, 1999, Li and Sikstrom, 2002), most notably episodic encoding (Bailey et al., 2000, Hedden and Gabrieli, 2004, Kandel and Pittenger, 1999). A similar deficit is expressed in the motor domain, impairing the ability to encode the kinematic features of a previously practiced motor task in the primary motor cortex as a function of training (Floel et al., 2005a, Sawaki et al., 2003).

Dopamine is a major neurotransmitter that strengthens the specificity and duration of formed memories (Goldman et al., 1998, Jay, 2003, Kandel, 2001, Williams and Goldman-Rakic, 1995). Dopaminergic function, including dopaminergic receptors, transporters and overall dopaminergic metabolic activity, are reduced with normal aging (Deisseroth et al., 1995, Emborg et al., 1998, Fearnley and Lees, 1991, Jay, 2003, Li and Sikstrom, 2002, Luo and Roth, 2000, Roth et al., 1995, Volkow et al., 1998). Previous work showed that administration of the dopamine precursor levodopa could enhance training effects on motor memory formation in healthy elderly subjects (Floel et al., 2005a) and stroke patients (Floel et al., 2005b), and appears to enhance motor rehabilitation (Scheidtmann et al., 2001), as do noradrenergic agents (Martinsson et al., 2003). One relative advantage in using dopaminergic agents versus, for example, amphetamines is that they exhibit fewer side-effects and may be safer (Feeney et al., 2004, Walker-Batson et al., 2004).

The findings of enhanced memory encoding in the elderly after administration of levodopa (Floel et al., 2005a) raise the hypothesis of a mechanistic link between dopaminergic function and training-induced motor memory formation. We reasoned that if such a link exists, administration of levodopa – which increases the presynaptic availability of endogenous dopamine – prior to training would lead to parallel increments in dopaminergic neurotransmission in task-relevant brain structures (Mawlawi et al., 2001, Schlosser et al., 1998) and in motor memory formation (Butefisch et al., 2000, Classen et al., 1998). Molecular imaging using the competitive D2 receptor ligand raclopride (RAC-positron emission tomography, PET) allows direct assessment of the brain dopamine system (Cropley et al., 2006). Endogenous release of dopamine increases synaptic dopamine concentration, resulting in increased occupancy of D2 receptors, and consequently decreased availability of dopamine D2 receptors for binding the radiotracer raclopride (Laruelle, 2000).

In the present study, we evaluated the effects of training plus levodopa on motor memory formation and on dopamine availability in the striatum. We also assessed levodopa effects on resting RAC-PET in the absence of training.

Section snippets

Subjects

Eleven healthy elderly subjects gave written informed consent and participated in this double-blind, placebo-controlled and randomized cross-over study. Four of them (age range 53–75 years, mean ± S.D.: 61 ± 10, one woman) participated to determine effects of levodopa on resting RAC-PET (CONDITIONresting dopamine release). Seven volunteers (age range 55–86 years, mean ± S.D.: 65 ± 10, three women) participated in the main study to identify training effects with and without levodopa on RAC-PET (CONDITION

Blood pressure, heart rate, attention, fatigue

Attention, fatigue, diastolic blood pressure and heart rate changes were comparable across CONDITIONtraining dopamine release, memory formation, DRUGlevodopa, placebo and TIMEbase, 15 min, post (see Table 2). In both CONDITIONtraining dopamine release and CONDITIONmemory formation, systolic blood pressure decreased over time to a similar extent with levodopa and placebo (main effects of TIME; linear trends, F(1,6) = 27.9, p = 0.002 and F(1,6) = 14.2, p = 0.022, respectively).

Unpaired t-tests between CONDITION

Discussion

The main findings of this study were that levodopa enhanced both training effects on motor memory formation and dopamine release in the dorsal caudate nucleus in healthy elderly subjects. The increase in dopamine release in the left caudate correlated with the magnitude of motor memory formation, indicative of a functional link between the two phenomena.

Acknowledgements

This work was supported by grants from the Deutsche Forschungsgemeinschaft to A.F. (Fl 379-4/1), the Bundesministerium für Forschung und Bildung to A.F. (01GW0520, part 4), the Interdisciplinary Center of Clinical Research Münster to S.K. (IZKF Projects FG2 and Kne3/074/04), the Innovative Medizinische Forschung Münster to A.F. (FL110605) and S.K. (KN520301) and the Volkswagen Stiftung to S.K. (Az.: I/80 708).

References (79)

  • V. Kaasinen et al.

    Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

    Neurobiol. Aging

    (2000)
  • S.C. Li et al.

    Integrative neurocomputational perspectives on cognitive aging, neuromodulation, and representation

    Neurosci. Biobehav. Rev.

    (2002)
  • R.C. Oldfield

    The assessment and analysis of handedness: the Edinburgh inventory

    Neuropsychologia

    (1971)
  • S. Otani et al.

    Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex

    Neuroscience

    (1998)
  • P.M. Rossini et al.

    Post-stroke plastic reorganisation in the adult brain

    Lancet Neurol.

    (2003)
  • G.S. Roth et al.

    Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging

    Trends Neurosci.

    (1995)
  • K. Scheidtmann et al.

    Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study

    Lancet

    (2001)
  • U. Ziemann et al.

    Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs

    Electroencephalogr. Clin. Neurophysiol.

    (1997)
  • A. Antonini et al.

    [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of l-dopa and lisuride therapy on striatal dopamine D2-receptors

    Neurology

    (1994)
  • C.H. Bailey et al.

    Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?

    Nat. Rev. Neurosci.

    (2000)
  • A. Breier et al.

    Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

    Proc. Natl. Acad. Sci. U.S.A.

    (1997)
  • Breitenstein, C., Korsukewitz, C., Floel, A., Zwitserlood, P., Knecht, S., 2006. Neuropsychopharmacology (epub ahead of...
  • D.J. Brooks

    Functional imaging studies on dopamine and motor control

    J. Neural. Transm.

    (2001)
  • S. Brunton

    A comprehensive approach to Parkinson's disease. How to manage fluctuating motor and nonmotor symptoms

    Postgrad. Med.

    (2006)
  • C.M. Butefisch et al.

    Modulation of use-dependent plasticity by d-amphetamine

    Ann. Neurol.

    (2002)
  • C.M. Butefisch et al.

    Mechanisms of use-dependent plasticity in the human motor cortex

    Proc. Natl. Acad. Sci. U.S.A.

    (2000)
  • R.E. Carson et al.

    Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion

    J. Cereb. Blood Flow Metab.

    (1997)
  • B.J. Casey et al.

    Clinical, imaging, lesion, and genetic approaches toward a model of cognitive control

    Dev. Psychobiol.

    (2002)
  • C. Cepeda et al.

    Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex

    Synapse

    (1992)
  • R. Chen et al.

    Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation

    Neurology

    (1997)
  • J. Classen et al.

    Rapid plasticity of human cortical movement representation induced by practice

    J. Neurophysiol.

    (1998)
  • R. de la Fuente-Fernandez et al.

    Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

    Brain

    (2004)
  • K. Doya et al.

    A novel reinforcement model of birdsong vocalization learning

  • M.E. Emborg et al.

    Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

    J. Comp. Neurol.

    (1998)
  • J.M. Fearnley et al.

    Ageing and Parkinson's disease: substantia nigra regional selectivity

    Brain

    (1991)
  • D.M. Feeney et al.

    Noradrenergic modulation of hemiplegia: facilitation and maintenance of recovery

    Restor. Neurol. Neurosci.

    (2004)
  • C.D. Fiorillo

    The uncertain nature of dopamine

    Mol. Psychiatry

    (2004)
  • A. Floel et al.

    Dopaminergic influences on formation of a motor memory

    Ann. Neurol.

    (2005)
  • A. Floel et al.

    Dopaminergic effects on encoding of a motor memory in chronic stroke

    Neurology

    (2005)
  • Cited by (72)

    • Cognitive Impairment in Alzheimer's and Metabolic Diseases: A Catecholaminergic Hypothesis

      2022, Neuroscience
      Citation Excerpt :

      Dopamine precursor L-DOPA has been used mainly as a Parkinson’s disease treatment to ameliorate motor symptoms by increasing DA levels (Abbott, 2010). Regarding cognitive functions in elderly subjects, a single dose of L-DOPA enhanced motor memory formation, suggesting a facilitatory role of DA on the engaged synapses during task training (Floel et al., 2008). However, chronic administration of L-DOPA in elderly subjects did not significantly improve performance in spatial or verbal tasks and induced adverse effects in 1/3 of the participants (Lebedev et al., 2020).

    • Reward and plasticity: Implications for neurorehabilitation

      2022, Handbook of Clinical Neurology
      Citation Excerpt :

      Interestingly, in healthy older adults reward induces higher ventral striatal activation than in younger adults (Widmer et al., 2017). Along those lines, upregulation of dopamine function in healthy older adults led to enhanced motor memory formation (Flöel et al., 2005; Floel et al., 2008). These data raise the hypothesis that reward incorporated into rehabilitative treatments could be more effective than training in the absence of reward.

    • Role of the nucleus accumbens in functional recovery from spinal cord injury

      2021, Neuroscience Research
      Citation Excerpt :

      Daily administration of l-Dopa in chronic post-stroke patients was significantly better than placebo plus physical therapy on motor recovery (Scheidtmann et al., 2001). These effects were likely attributable to dopamine because studies in rodents (Doshi and Edwards, 1981), non-human primates (Firnau et al., 1987), and humans (Floel et al., 2008) indicate that systemic administration of l-Dopa increases the brain concentration of dopamine, but not norepinephrine. Dopamine is the predominant brain metabolite formed from systemic l-Dopa.

    • Accelerated habitual learning resulting from L-dopa exposure in rats is prevented by N-acetylcysteine

      2020, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Notably in human studies, L-dopa has been shown to enhance reward-learning and cognition, in line with the recognized role of dopamine in these processes (Knecht et al., 2004; Shellshear et al., 2015; Ripolles et al., 2018; Guitart-Masip et al., 2014; Pessiglione et al., 2006). Of particular relevance to the current study, it has been demonstrated that L-dopa influences choice-based instrumental behavior, as well as improving striatal-based or procedural learning tasks in healthy individuals (Floel et al., 2008; de Vries et al., 2010; Wunderlich et al., 2012). However, other human studies report negative or no effects of L-dopa on cognition (Vo et al., 2016; Vo et al., 2017; Grogan et al., 2019), and thus additional animal studies will aid in determining the types of learning that are modulated by L-dopa and whether L-dopa may be a cognitive enhancer.

    View all citing articles on Scopus
    View full text